A Phase III Randomized Study of BBI608 and Best Supportive Care Versus Placebo and Best Supportive Care in Patients With Pretreated Advanced Colorectal Carcinoma

Trial Profile

A Phase III Randomized Study of BBI608 and Best Supportive Care Versus Placebo and Best Supportive Care in Patients With Pretreated Advanced Colorectal Carcinoma

Completed
Phase of Trial: Phase III

Latest Information Update: 24 Nov 2016

At a glance

  • Drugs Napabucasin (Primary)
  • Indications Colorectal cancer
  • Focus Registrational; Therapeutic Use
  • Sponsors Sumitomo Dainippon Pharma
  • Most Recent Events

    • 11 Oct 2016 Results assessing efficacy and analysing biomarker for response, presented at the 41st European Society for Medical Oncology Congress
    • 06 Oct 2016 According to a Sumitomo Dainippon Pharma media release, study results will be presented at the ESMO 2016 Congress
    • 06 Oct 2016 Results published in the Sumitomo Dainippon Pharma media release.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top